What does Dr. Matteo Pettinari en Dr. Karolien Paeme do?

Dr. Matteo Pettinari en Dr. Karolien Paeme is a specialist medical practice in Lubbeek. Private Limited, started on 12 March 2018, 1 establishment.

What is the address of Dr. Matteo Pettinari en Dr. Karolien Paeme?

The registered office of Dr. Matteo Pettinari en Dr. Karolien Paeme is located at Wauwerdries(LUB) 33, 3210 Lubbeek.

Is Dr. Matteo Pettinari en Dr. Karolien Paeme still active?

Yes. According to the CBE (18 September 2026) Dr. Matteo Pettinari en Dr. Karolien Paeme is active, legal situation “Normale toestand”, started on 12 March 2018.

Is Dr. Matteo Pettinari en Dr. Karolien Paeme registered on Peppol?

Yes, Dr. Matteo Pettinari en Dr. Karolien Paeme is registered on the Peppol network with ID 0208:0691944649.

What is the enterprise number of Dr. Matteo Pettinari en Dr. Karolien Paeme?

The enterprise number of Dr. Matteo Pettinari en Dr. Karolien Paeme is BE0691944649.

When was Dr. Matteo Pettinari en Dr. Karolien Paeme founded?

Dr. Matteo Pettinari en Dr. Karolien Paeme was founded on 12 March 2018.

Who are the directors of Dr. Matteo Pettinari en Dr. Karolien Paeme?

According to the 2025 annual accounts, the directors of Dr. Matteo Pettinari en Dr. Karolien Paeme are: Matteo Pettinari, Karolien Paeme.

Is Dr. Matteo Pettinari en Dr. Karolien Paeme a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 March 2018; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. Matteo Pettinari en Dr. Karolien Paeme make in 2025?

Dr. Matteo Pettinari en Dr. Karolien Paeme posted a profit after taxes of € 31,189 in financial year 2025.

What is the revenue of Dr. Matteo Pettinari en Dr. Karolien Paeme?

As a small company, Dr. Matteo Pettinari en Dr. Karolien Paeme is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 162,635.

Dr. Matteo Pettinari en Dr. Karolien Paeme (Private Limited)

Dossier Dr. Matteo Pettinari en Dr. Karolien Paeme, printed on 18 September 2026 from databakkes.be/en/0691944649/dr-matteo-pettinari-en-dr-karolien-paeme. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Matteo Pettinari en Dr. Karolien Paeme from Lubbeek, company number BE0691944649, closed financial year 2025 with a result of € 31,189 after tax. For that financial year Dr. Matteo Pettinari en Dr. Karolien Paeme recorded a gross margin of € 162,635 and equity of € 292,991. Compared with financial year 2024, the result moved from € 48,509 to € 31,189. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 292,991

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 31,189

▼ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 219,393

▲ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 274,391.

People and assets in 2025

Vehicles and equipment

€ 7,095

▼ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 58,677

▼ 60% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 4,412

▲ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 341

▼ 99% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 227,672 Gross margin 2022: € 227,672 First fiscal year in the series	€ 122,036 Gross margin 2023: € 122,036 ▼ 46% vs 2022 (€ 227,672) Unfavourable step	€ 182,823 Gross margin 2024: € 182,823 ▲ 50% vs 2023 (€ 122,036) Favourable step	€ 162,635 Gross margin 2025: € 162,635 ▼ 11% vs 2024 (€ 182,823) Unfavourable step	▼ 11%
Profit after taxes	€ 83,305 Profit after taxes 2022: € 83,305 First fiscal year in the series	€ -974 Profit after taxes 2023: € -974 ▼ € 84,279 vs 2022 (€ 83,305) Unfavourable step	€ 48,509 Profit after taxes 2024: € 48,509 ▲ € 49,483 vs 2023 (€ -974) Favourable step	€ 31,189 Profit after taxes 2025: € 31,189 ▼ 36% vs 2024 (€ 48,509) Unfavourable step	▼ 36%
Equity	€ 564,267 Equity 2022: € 564,267 First fiscal year in the series	€ 513,293 Equity 2023: € 513,293 ▼ 9% vs 2022 (€ 564,267) Unfavourable step	€ 261,802 Equity 2024: € 261,802 ▼ 49% vs 2023 (€ 513,293) Unfavourable step	€ 292,991 Equity 2025: € 292,991 ▲ 12% vs 2024 (€ 261,802) Favourable step	▲ 12%
Total debts	€ 447,335 Total debts 2022: € 447,335 First fiscal year in the series	€ 242,049 Total debts 2023: € 242,049 ▼ 46% vs 2022 (€ 447,335) Favourable step	€ 357,516 Total debts 2024: € 357,516 ▲ 48% vs 2023 (€ 242,049) Unfavourable step	€ 240,311 Total debts 2025: € 240,311 ▼ 33% vs 2024 (€ 357,516) Favourable step	▼ 33%
Cash	€ 251,935 Cash 2022: € 251,935 First fiscal year in the series	€ 69,683 Cash 2023: € 69,683 ▼ 72% vs 2022 (€ 251,935) Unfavourable step	€ 183,220 Cash 2024: € 183,220 ▲ 163% vs 2023 (€ 69,683) Favourable step	€ 219,393 Cash 2025: € 219,393 ▲ 20% vs 2024 (€ 183,220) Favourable step	▲ 20%
Retained profit	€ 545,667 Retained profit 2022: € 545,667 First fiscal year in the series	€ 494,693 Retained profit 2023: € 494,693 ▼ 9% vs 2022 (€ 545,667) Unfavourable step	€ 243,202 Retained profit 2024: € 243,202 ▼ 51% vs 2023 (€ 494,693) Unfavourable step	€ 274,391 Retained profit 2025: € 274,391 ▲ 13% vs 2024 (€ 243,202) Favourable step	▲ 13%
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 50,000 Dividend 2023: € 50,000 ▼ 50% vs 2022 (€ 100,000) Unchanged	€ 300,000 Dividend 2024: € 300,000 ▲ € 250,000 vs 2023 (€ 50,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 300,000) Unchanged	▼ 100%
Bank debt	€ 318,682 Bank debt 2022: € 318,682 First fiscal year in the series	€ 232,740 Bank debt 2023: € 232,740 ▼ 27% vs 2022 (€ 318,682) Favourable step	€ 146,077 Bank debt 2024: € 146,077 ▼ 37% vs 2023 (€ 232,740) Favourable step	€ 58,677 Bank debt 2025: € 58,677 ▼ 60% vs 2024 (€ 146,077) Favourable step	▼ 60%
Balance sheet total	€ 1,011,602 Balance sheet total 2022: € 1,011,602 First fiscal year in the series	€ 755,342 Balance sheet total 2023: € 755,342 ▼ 25% vs 2022 (€ 1,011,602) Unchanged	€ 619,317 Balance sheet total 2024: € 619,317 ▼ 18% vs 2023 (€ 755,342) Unchanged	€ 533,302 Balance sheet total 2025: € 533,302 ▼ 14% vs 2024 (€ 619,317) Unchanged	▼ 14%

Key figures of Dr. Matteo Pettinari en Dr. Karolien Paeme, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Matteo Pettinari en Dr. Karolien Paeme?

What happened at Dr. Matteo Pettinari en Dr. Karolien Paeme in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 31,189 (▼ 36% vs 2024). filed late Source: NBB ↗
Mar 12, 2018 New establishment in Genk. KBO
2018 Matteo Pettinari became a director. NBB
2018 Karolien Paeme became a director. NBB
Mar 12, 2018 Start of the company according to the CBE. KBO

In short

From € 83,305 profit in 2022 to € 31,189 profit in 2025.

Paid € 55,603 in corporate taxes since 2022.

Best year ever: 2022, with € 83,305 profit.

Paid out € 450,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Matteo Pettinari en Dr. Karolien Paeme? We notify you, reason included.

Follow Dr. Matteo Pettinari en Dr. Karolien Paeme

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Matteo Pettinari Karolien Paeme

Dr. Matteo Pettinari en Dr. Karolien Paeme

Behind Dr. Matteo Pettinari en Dr. Karolien Paeme are Matteo Pettinari and Karolien Paeme.

See the full network in the app

Directors

According to the 2025 annual accounts

Matteo Pettinari

Director

since 2018

Karolien Paeme

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Wauwerdries(LUB) 33

3210 Lubbeek

2.274.820.541

Synaps Park 1

3600 Genk

Active since 12 March 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0691.944.649
VAT number: BE 0691.944.649
Registered office: Wauwerdries(LUB) 33, 3210 Lubbeek
Names & denominations: Dr. Matteo Pettinari en Dr. Karolien Paeme
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 March 2018
Peppol: Active · Active since 24 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗